The 86-year-old business tycoon and philanthropist, who lives in the United States, was awarded the 2022 Gallatin Award by the Swiss-American Chamber of Commerce on Tuesday. The award was handed over by Swiss Economics Minister Guy Parmelin.
“The ongoing commitment of Hansjörg Wyss and his foundation to support ground-breaking research in Switzerland and elsewhere is more than a gift: it is a strong symbol of confidence in science and in the scientists who make it live on a daily basis,” saidExternal link Parmelin in his speech.
Over the past ten years Wyss has donated over CHF500 million ($502 million) to ground-breaking research projects in Switzerland via his Wyss centres and academy in Zurich, Geneva and Bern. Each centre works closely with leading Swiss universities, such as the two federal institutes, EPFL and ETH Zurich, on projects ranging from robotics to medicine. These have resulted in over 250 jobs and 25 spin-off companies.
Giving Pledge
Wyss made his fortune by selling his company Synthes to the American multinational Johnson & Johnson in 2012. The magazine Forbes estimates his net worth at $5 billion. In 2017 it described him as “one of the most philanthropic people in the world”.
Wyss has signed the so-called “Giving Pledge”External link to agree to give away the majority of his fortune to charity.
Wyss has been in the news recently for his involvement in a consortium bid, fronted by Los Angeles Dodgers part-owner Todd Boehly, to buy the English Premier League football club Chelsea. The British government has yet to approve the sale of the London club, which was previously owned by Russian billionaire Roman Abramovich.
The Gallatin AwardExternal link, which is given every three to four years, celebrates people who have helped bring Switzerland and the US closer together. The award is named after Albert Gallatin, born in Geneva in 1761, who was the longest-serving US Secretary of Treasury, founder of New York University and the Bank of New York.
Popular Stories
More
Multinational companies
Azeri fossil-fuel cash cow brings controversy to Switzerland
Swiss price watchdog slams excessive prices for generic medicines
This content was published on
The cheapest generic medicines available in Switzerland are more than twice as expensive as in other countries, according to a study by the Swiss price watchdog.
Nature should not figure in net zero calculations: academic study
This content was published on
The natural removal of CO2 from the atmosphere by forests or oceans should not be included in the net-zero balance of climate protection measures, argue researchers.
This content was published on
None of the 15 major Swiss retail banks is meeting international climate and biodiversity targets, according to a ranking by WWF Switzerland.
This content was published on
Nestlé's new CEO Laurent Freixe, has presented plans for the future of the world's largest food company, after his first few weeks in office.
Swiss foreign minister calls on Moscow to end Ukraine war
This content was published on
It's high time Moscow ended its war against Ukraine, Swiss foreign minister Ignazio Cassis tells the UN Security Council.
This content was published on
The only alternative to the UN Palestinian agency’s work in Gaza is to allow Israel to run services there, Philippe Lazzarini, UNRWA Commissioner-General, told reporters in Geneva on Monday.
Study reveals food culture differences between Switzerland and neighbours
This content was published on
Three-quarters of Swiss people consider eating to be a pleasurable, social activity, a new survey reveals. Healthy eating, however, plays a much less important role, it found.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Eight Swiss in Bloomberg billionaire ‘rich list’
This content was published on
In the latest version of the Bloomberg Billionaires Index, eight Swiss or Swiss-resident names figure among the 500 richest people in the world.
Billionaire’s cash brings medical research to patients
This content was published on
The collaboration between the University of Zurich and the Swiss Federal Institute of Technology Zurich (ETHZ) will ‘bridge’ the often difficult phase between pure research and its practical application outside of the laboratory. It is the second such project in Switzerland that Wyss has funded with a donation of more than CHF100 million. It follows…
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.